UnitedHealth Group Inc (UNH) is CCM Investment Advisers LLC’s 7th Largest Position

CCM Investment Advisers LLC reduced its position in UnitedHealth Group Inc (NYSE:UNH) by 1.9% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 47,417 shares of the healthcare conglomerate’s stock after selling 907 shares during the period. UnitedHealth Group comprises about 2.3% of CCM Investment Advisers LLC’s portfolio, making the stock its 7th biggest holding. CCM Investment Advisers LLC’s holdings in UnitedHealth Group were worth $12,614,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of UNH. FMR LLC lifted its stake in shares of UnitedHealth Group by 5.1% in the 2nd quarter. FMR LLC now owns 61,622,355 shares of the healthcare conglomerate’s stock valued at $15,118,428,000 after purchasing an additional 2,981,233 shares during the period. Vontobel Asset Management Inc. acquired a new position in shares of UnitedHealth Group in the 2nd quarter valued at $404,980,000. Janus Henderson Group PLC lifted its stake in shares of UnitedHealth Group by 61.7% in the 2nd quarter. Janus Henderson Group PLC now owns 3,525,090 shares of the healthcare conglomerate’s stock valued at $864,869,000 after purchasing an additional 1,345,083 shares during the period. Chevy Chase Trust Holdings Inc. acquired a new position in shares of UnitedHealth Group in the 2nd quarter valued at $248,898,000. Finally, Fred Alger Management Inc. lifted its stake in shares of UnitedHealth Group by 30.8% in the 2nd quarter. Fred Alger Management Inc. now owns 3,477,091 shares of the healthcare conglomerate’s stock valued at $853,070,000 after purchasing an additional 817,987 shares during the period. Hedge funds and other institutional investors own 85.47% of the company’s stock.

In other news, Director Richard T. Burke sold 20,000 shares of the company’s stock in a transaction on Wednesday, September 12th. The shares were sold at an average price of $263.41, for a total transaction of $5,268,200.00. Following the completion of the sale, the director now owns 1,720,112 shares of the company’s stock, valued at $453,094,701.92. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, EVP D Ellen Wilson sold 15,393 shares of the company’s stock in a transaction on Friday, August 24th. The stock was sold at an average price of $264.29, for a total transaction of $4,068,215.97. Following the sale, the executive vice president now directly owns 66,402 shares of the company’s stock, valued at approximately $17,549,384.58. The disclosure for this sale can be found here. Insiders have sold 69,731 shares of company stock valued at $18,584,675 over the last 90 days. 0.87% of the stock is currently owned by company insiders.



Several research firms recently issued reports on UNH. BMO Capital Markets boosted their target price on shares of UnitedHealth Group to $310.00 and gave the company an “outperform” rating in a research note on Thursday, October 18th. Argus boosted their target price on shares of UnitedHealth Group to $285.00 and gave the company a “buy” rating in a research note on Thursday, October 18th. Oppenheimer boosted their target price on shares of UnitedHealth Group from $276.00 to $295.00 and gave the company an “outperform” rating in a research note on Wednesday, October 17th. Royal Bank of Canada boosted their target price on shares of UnitedHealth Group to $308.00 and gave the company an “outperform” rating in a research note on Wednesday, October 17th. Finally, Piper Jaffray Companies boosted their target price on shares of UnitedHealth Group to $300.00 and gave the company an “overweight” rating in a research note on Wednesday, October 17th. One analyst has rated the stock with a hold rating, twenty-two have issued a buy rating and one has assigned a strong buy rating to the company’s stock. UnitedHealth Group has a consensus rating of “Buy” and a consensus target price of $289.41.

NYSE:UNH opened at $264.94 on Friday. The company has a quick ratio of 0.69, a current ratio of 0.69 and a debt-to-equity ratio of 0.61. The firm has a market cap of $262.04 billion, a price-to-earnings ratio of 26.31, a P/E/G ratio of 1.57 and a beta of 0.78. UnitedHealth Group Inc has a fifty-two week low of $208.48 and a fifty-two week high of $278.00.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 16th. The healthcare conglomerate reported $3.41 earnings per share for the quarter, topping the Zacks’ consensus estimate of $3.30 by $0.11. The company had revenue of $56.56 billion during the quarter, compared to analysts’ expectations of $56.34 billion. UnitedHealth Group had a net margin of 5.71% and a return on equity of 23.63%. The firm’s revenue for the quarter was up 12.4% on a year-over-year basis. During the same period in the prior year, the business posted $2.66 earnings per share. As a group, equities research analysts predict that UnitedHealth Group Inc will post 12.81 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 13th. Shareholders of record on Monday, December 3rd will be given a dividend of $0.90 per share. This represents a $3.60 dividend on an annualized basis and a yield of 1.36%. The ex-dividend date is Friday, November 30th. UnitedHealth Group’s dividend payout ratio is presently 35.75%.

COPYRIGHT VIOLATION NOTICE: “UnitedHealth Group Inc (UNH) is CCM Investment Advisers LLC’s 7th Largest Position” was originally reported by Dakota Financial News and is owned by of Dakota Financial News. If you are viewing this piece on another site, it was copied illegally and republished in violation of United States and international trademark and copyright laws. The correct version of this piece can be viewed at https://dakotafinancialnews.com/2018/11/16/unitedhealth-group-inc-unh-is-ccm-investment-advisers-llcs-7th-largest-position.html.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Further Reading: What is Considered a Good Return on Equity (ROE)?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply